CRISPR-Cas Genome Surgery in Ophthalmology.

作者: James E. DiCarlo , Jesse D. Sengillo , Sally Justus , Thiago Cabral , Stephen H. Tsang

DOI: 10.1167/TVST.6.3.13

关键词:

摘要: Genetic disease affecting vision can significantly impact patient quality of life. Gene therapy seeks to slow the progression these diseases by treating underlying etiology at level genome. Clustered regularly interspaced short palindromic repeats (CRISPR) and CRISPR-associated systems (Cas) represent powerful tools for studying through creation model organisms generated targeted modification correction mutations therapeutic purposes. CRISPR-Cas have been applied successfully visual sciences study ophthalmic - from zebrafish mammalian models eye development disease, pathogenic in patient-derived stem cells. Recent advances delivery optimization boast improved functionality that continues enhance genome-engineering applications eye. This review provides a synopsis recent implementations field ophthalmology.

参考文章(95)
Hua Zhong, Yiyun Chen, Yumei Li, Rui Chen, Graeme Mardon, CRISPR-engineered mosaicism rapidly reveals that loss of Kcnj13 function in mice mimics human disease phenotypes Scientific Reports. ,vol. 5, pp. 8366- 8366 ,(2015) , 10.1038/SREP08366
Fred Griffith, The Significance of Pneumococcal Types. Journal of Hygiene. ,vol. 27, pp. 113- 159 ,(1928) , 10.1017/S0022172400031879
Wenyan Jiang, David Bikard, David Cox, Feng Zhang, Luciano A Marraffini, RNA-guided editing of bacterial genomes using CRISPR-Cas systems Nature Biotechnology. ,vol. 31, pp. 233- 239 ,(2013) , 10.1038/NBT.2508
Nannan Chang, Changhong Sun, Lu Gao, Dan Zhu, Xiufei Xu, Xiaojun Zhu, Jing-Wei Xiong, Jianzhong Jeff Xi, Genome editing with RNA-guided Cas9 nuclease in Zebrafish embryos Cell Research. ,vol. 23, pp. 465- 472 ,(2013) , 10.1038/CR.2013.45
Francesca Simonelli, Albert M Maguire, Francesco Testa, Eric A Pierce, Federico Mingozzi, Jeannette L Bennicelli, Settimio Rossi, Kathleen Marshall, Sandro Banfi, Enrico M Surace, Junwei Sun, T Michael Redmond, Xiaosong Zhu, Kenneth S Shindler, Gui-Shuang Ying, Carmela Ziviello, Carmela Acerra, J Fraser Wright, Jennifer Wellman McDonnell, Katherine A High, Jean Bennett, Alberto Auricchio, Gene therapy for Leber's congenital amaurosis is safe and effective through 1.5 years after vector administration. Molecular Therapy. ,vol. 18, pp. 643- 650 ,(2010) , 10.1038/MT.2009.277
Prashant Mali, Luhan Yang, Kevin M Esvelt, John Aach, Marc Guell, James E DiCarlo, Julie E Norville, George M Church, RNA-Guided Human Genome Engineering via Cas9 Science. ,vol. 339, pp. 823- 826 ,(2013) , 10.1126/SCIENCE.1232033
Shengdar Q Tsai, Zongli Zheng, Nhu T Nguyen, Matthew Liebers, Ved V Topkar, Vishal Thapar, Nicolas Wyvekens, Cyd Khayter, A John Iafrate, Long P Le, Martin J Aryee, J Keith Joung, GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases Nature Biotechnology. ,vol. 33, pp. 187- 197 ,(2015) , 10.1038/NBT.3117
S. Chandrasegaran, J. Smith, Chimeric restriction enzymes: what is next? Biological Chemistry. ,vol. 380, pp. 841- 848 ,(1999) , 10.1515/BC.1999.103
L. S. Kean, M. M. Davis, J. C. Wu, J. I. Pearl, Pluripotent stem cells: immune to the immune system? Science Translational Medicine. ,vol. 4, ,(2012) , 10.1126/SCITRANSLMED.3005090